Liquid bone healer could replace grafts for dental implants

NCT ID NCT07707388

Not yet recruiting Disease control Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests whether a liquid called Theravex can improve healing and stability when a dental implant is placed right after a tooth is pulled. Theravex is applied directly into the gap between the implant and the bone socket to stimulate bone growth. Researchers compare it to a standard bone graft and a combination of both in 30 people needing a front tooth implant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a bone bioactive liquid called Theravex, applied directly to the implant site to stimulate bone healing
What this could lead to: If successful, Theravex could offer a simpler, faster-healing alternative to traditional bone grafts for dental implants.
What could go wrong: This is a small, early-stage trial with only 30 participants, so results may not apply to everyone. Theravex is new and its long-term benefits over standard grafts are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMEDIATE DENTAL IMPLANT PLACEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

capillary malformation-arteriovenous malformation syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMEDIATE DENTAL IMPLANT PLACEMENT

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Faculty of Dentistry - Ain Shams University

Cairo, 11566, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.